1. Home
  2. FURY vs RANI Comparison

FURY vs RANI Comparison

Compare FURY & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fury Gold Mines Limited

FURY

Fury Gold Mines Limited

HOLD

Current Price

$0.53

Market Cap

111.2M

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.77

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FURY
RANI
Founded
2008
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.2M
106.9M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
FURY
RANI
Price
$0.53
$0.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$1.70
$7.50
AVG Volume (30 Days)
290.4K
1.1M
Earning Date
08-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
N/A
N/A
Revenue
N/A
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
58.85
52 Week Low
$0.46
$0.39
52 Week High
$1.02
$3.87

Technical Indicators

Market Signals
Indicator
FURY
RANI
Relative Strength Index (RSI) 39.15 37.00
Support Level $0.51 $0.70
Resistance Level $0.63 $1.05
Average True Range (ATR) 0.02 0.06
MACD -0.00 -0.02
Stochastic Oscillator 33.33 4.26

Price Performance

Historical Comparison
FURY
RANI

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: